Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement
Pediatric Pulmonology · 2023-10 · 58 (10) · 2761-2768
DOI: 10.1002/ppul.26576 ↗At a glance
Journal article in Pediatric Pulmonology, published online on 2023-06-28. Written by Laura Vivalda and 4 co-authors. Institution: Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France. Major MEDLINE topics: Chorioamnionitis, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactants. Cited 6 times so far (Crossref); 39 references.
Abstract (original language)
Objective
Lung ultrasound score (LUS) accurately guides surfactant replacement in preterm neonates with respiratory distress syndrome due to surfactant deficiency. However, surfactant deficiency is not the unique pathobiological feature, as there may be relevant lung inflammation, such as in certain cases of clinical chorioamnionitis (CC). We aim to investigate if CC influences LUS and ultrasound‐guided surfactant treatment.
Design
Retrospective (2017–2022), large, cohort study targeted to recruit a homogeneous population treated with unchanged respiratory care policy and lung ultrasound protocol. Patients with (CC+: 207) and without (CC−: 205) chorioamnionitis were analyzed with propensity score matching and subsequent additional multivariate adjustments.
Results
LUS was identical at unmatched and matched comparisons. Consistently, at least one surfactant dose was given in 98 (47.3%) and 83 (40.5%) neonates in the CC+ and CC− matched cohorts, respectively ( p = .210). Multiple doses were needed in 28 (13.5%) and 21 (10.2%) neonates in the CC+ and CC− cohorts, respectively ( p = .373). Postnatal age at surfactant dosing was also similar. LUS was higher in patients who were diagnosed with neonatal acute respiratory distress syndrome (NARDS) (CC+ cohort: 10.3 (2.9), CC− cohort: 11.4 (2.6)), than in those without NARDS (CC+ cohort: 6.1 (3.7), CC− cohort: 6.2 (3.9); p < .001, for both). Surfactant use was more frequent in neonates with, than in those without NARDS ( p < .001). Multivariate adjustments confirmed NARDS as the variable with greater effect size on LUS.
Conclusions
CC does not influence LUS in preterm neonates, unless inflammation is enough severe to trigger NARDS. The occurrence of NARDS is key factor influencing the LUS.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.
- Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris-Saclay University, Paris, France.
ORCID profiles: Daniele De Luca
Cite
APA
Vivalda, L., Loi, B., Bisceglie, V., Ben-Ammar, R., & De Luca, D. (2023). Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement. Pediatric Pulmonology, 58(10), 2761-2768. https://doi.org/10.1002/ppul.26576
Vancouver
Vivalda L, Loi B, Bisceglie V, Ben-Ammar R, De Luca D. Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement. Pediatric Pulmonology. 2023;58(10):2761-2768. doi:10.1002/ppul.26576
BibTeX
@article{Vivalda2023,
author = {Vivalda, Laura and Loi, Barbara and Bisceglie, Valeria and Ben-Ammar, Rafik and De Luca, Daniele},
title = {Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement},
journal = {Pediatric Pulmonology},
year = {2023},
volume = {58},
number = {10},
pages = {2761--2768},
doi = {10.1002/ppul.26576}
}
EUVIMED